EconomyRoche beats revenue estimates, but copycats weigh on Xolair sales and shares slip

Swiss drugmaker Roche exceeded third-quarter sales expectations on Thursday, with steady demand for key medicines such as Ocrevus providing support. The company is using the time to seek pipeline additions abroad as looming patent expiries approach.

Rochepharmaceuticalsquarterly earningsXolair

RReuters★★☆☆☆2026-10-22 08:50Original